Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 2
1961 5
1962 4
1963 3
1964 4
1965 3
1966 5
1967 8
1968 2
1969 4
1974 2
1975 1
1976 2
1978 1
1979 5
1980 10
1981 5
1982 7
1983 5
1984 3
1985 1
1986 5
1987 1
1988 6
1989 1
1990 2
1991 2
1992 2
1993 1
1994 2
1996 1
1998 1
2000 1
2001 1
2002 1
2003 3
2004 1
2005 3
2006 2
2007 2
2008 2
2009 3
2010 1
2012 3
2013 9
2014 18
2015 15
2016 18
2017 20
2018 25
2019 32
2020 29
2021 23
2022 16
2023 25
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma.
Jiang L, Qin J, Dai Y, Zhao S, Zhan Q, Cui P, Ren L, Wang X, Zhang R, Gao C, Zhou Y, Cai S, Wang G, Xie W, Tang X, Shi M, Ma F, Liu J, Wang T, Wang C, Svrcek M, Bardier-Dupas A, Emile JF, de Mestier L, Bachet JB, Nicolle R, Cros J, Laurent-Puig P, Wei M, Song B, Jing W, Guo S, Zheng K, Jiang H, Wang H, Deng X, Chen H, Tian Q, Wang S, Shi S, Jin G, Yin T, Fang H, Chen S, Shen B. Jiang L, et al. Among authors: cros j. Nat Med. 2024 Mar;30(3):749-761. doi: 10.1038/s41591-023-02790-x. Epub 2024 Jan 29. Nat Med. 2024. PMID: 38287168
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J, Franchimont D, Verset L, Galdon MG, Devière J, de Reyniès A, Laurent-Puig P, Van Laethem JL, Bachet JB, Maréchal R. Puleo F, et al. Among authors: cros j. Gastroenterology. 2018 Dec;155(6):1999-2013.e3. doi: 10.1053/j.gastro.2018.08.033. Epub 2018 Aug 27. Gastroenterology. 2018. PMID: 30165049
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M, Tosolini M, Wilson AS, Delvecchio FR, Bousquet C, Paradis V, Hammel P, Sadanandam A, Kocher HM. Neuzillet C, et al. Among authors: cros j. J Pathol. 2019 May;248(1):51-65. doi: 10.1002/path.5224. Epub 2019 Feb 22. J Pathol. 2019. PMID: 30575030 Free PMC article.
[An astonishing diagnosis!].
Morini A, Burys A, Cazals-Hatem D, Sauvanet A, Fléjou JF, Cros J. Morini A, et al. Among authors: cros j. Ann Pathol. 2023 Sep;43(5):421-424. doi: 10.1016/j.annpat.2023.01.002. Epub 2023 Jan 24. Ann Pathol. 2023. PMID: 36702725 French. No abstract available.
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability.
Ratovomanana T, Nicolle R, Cohen R, Diehl A, Siret A, Letourneur Q, Buhard O, Perrier A, Guillerm E, Coulet F, Cervera P, Benusiglio P, Labrèche K, Colle R, Collura A, Despras E, Le Rouzic P, Renaud F, Cros J, Alentorn A, Touat M, Ayadi M, Bourgoin P, Prunier C, Tournigand C, Fouchardière C, Tougeron D, Jonchère V, Bennouna J, de Reynies A, Fléjou JF, Svrcek M, André T, Duval A. Ratovomanana T, et al. Among authors: cros j. Ann Oncol. 2023 Aug;34(8):703-713. doi: 10.1016/j.annonc.2023.05.010. Epub 2023 Jun 1. Ann Oncol. 2023. PMID: 37269904
5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours.
de Mestier L, Cros J, Hammel P. de Mestier L, et al. Among authors: cros j. Pancreatology. 2017 Jul-Aug;17(4):527-528. doi: 10.1016/j.pan.2017.06.004. Epub 2017 Jun 8. Pancreatology. 2017. PMID: 28619285 No abstract available.
Tumor Heterogeneity in Pancreatic Adenocarcinoma.
Cros J, Raffenne J, Couvelard A, Poté N. Cros J, et al. Pathobiology. 2018;85(1-2):64-71. doi: 10.1159/000477773. Epub 2017 Aug 5. Pathobiology. 2018. PMID: 28787741 Free article. Review.
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P. de Mestier L, et al. Among authors: cros j. Neuroendocrinology. 2017;105(4):412-425. doi: 10.1159/000475527. Epub 2017 Aug 12. Neuroendocrinology. 2017. PMID: 28803232 Free article. Review.
PARP inhibition in treatment of pancreatic cancer.
Hammel P, Zhang C, Matile J, Colle E, Hadj-Naceur I, Gagaille MP, Bouattour M, Cros J, de Mestier L, Lamuraglia M. Hammel P, et al. Among authors: cros j. Expert Rev Anticancer Ther. 2020 Nov;20(11):939-945. doi: 10.1080/14737140.2020.1820330. Epub 2020 Sep 16. Expert Rev Anticancer Ther. 2020. PMID: 32936674 Review.
326 results